Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPM8 | Q7Z2W7 | 4/20 | 0.47 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.34 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1358316 | 0.85 | TRPM8 (0.47) | TRPM8TRPA1EPHX1ALDH1A1KCNA5 | |
| SCHEMBL28534669 | 0.80 | TRPM8 (0.43) | TRPM8TRPA1EPHX1ALDH1A1KCNA5 | |
| SCHEMBL26355350 | 0.78 | TRPM8 (0.52) | TRPM8TRPA1EPHX1ALDH1A1KCNA5 | |
| SCHEMBL15435867 | 0.78 | TRPM8 (0.52) | TRPM8TRPA1EPHX1ALDH1A1KCNA5 | |
| SCHEMBL15435866 | 0.76 | TRPM8 (0.50) | TRPM8TRPA1EPHX1ALDH1A1KCNA5 | |
| SCHEMBL31105805 | 0.74 | TRPM8 (0.48) | TRPM8TRPA1EPHX1ALDH1A1KCNA5 | |
| SCHEMBL16445966 | 0.74 | TRPM8 (0.48) | TRPM8TRPA1EPHX1ALDH1A1KCNA5 | |
| SCHEMBL6335743 | 0.73 | TRPM8 (0.52) | TRPM8TRPA1EPHX1ALDH1A1KCNA5 | |
| SCHEMBL5307491 | 0.73 | TRPM8 (0.47) | TRPM8TRPA1EPHX1ALDH1A1KCNA5 | |
| SCHEMBL10642094 | 0.72 | TRPM8 (0.46) | TRPM8TRPA1EPHX1ALDH1A1KCNA5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7250446-B2 | Mercaptophenyl naphthyl methane compounds and synthesis thereof | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2007-07-31 | — | — | US | claimed |
| US-20040229869-A1 | Novel mercaptophenyl naphthyl methane compounds and synthesis thereof | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2004-11-18 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040229869-A1 | Novel mercaptophenyl naphthyl methane compounds and synthesis thereof | BRCA1, PGR, APC | TRPM8 1803/4885TRPA1 2526/4885EPHX1 2615/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.